Results 191 to 200 of about 8,567,027 (419)

Transportation Funding Alternatives:A Preliminary Analysis [PDF]

open access: yes, 2007
This report explores issues associated with proposed alternative revenue sources for increasing transportation for funding.
David L. Sjoquist   +3 more
core   +1 more source

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

open access: yesMolecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou   +11 more
wiley   +1 more source

THE FIVE HUNDRED POUNDS MEDICAL REFORM FUND. [PDF]

open access: green
FrederickSmith Garlick   +8 more
openalex   +1 more source

FUND FOR BELGIAN AND FRENCH PHYSICIANS [PDF]

open access: green, 1917
Henry Barton Jacobs
openalex   +1 more source

International Conference on Litigation Funding [PDF]

open access: yes, 2010
The aim of the research is to examine the potential for third party litigation funding as a tool to increase access to justice and overcome some of the obstacles faced by some plaintiffs due to the high costs of litigation.
Hodges, Christopher   +2 more
core  

Robust acute myeloid leukemia engraftment in humanized scaffolds using injectable biomaterials and intravenous xenotransplantation

open access: yesMolecular Oncology, EarlyView.
Patient‐derived xenografts (PDXs) can be improved by implantation of a humanized niche. We tested different biomaterials and approaches, and demonstrate that the combination of an injectable biomaterial for scaffold creation plus an intravenous route for acute myeloid leukemia (AML) xenotransplantation provide the most convenient and robust approach to
Daniel Busa   +13 more
wiley   +1 more source

KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells

open access: yesMolecular Oncology, EarlyView.
We demonstrate that decitabine (DEC) not only degrades the DNA methyltransferase DNMT1 but also the leukemic driver lysine methyltransferase KMT2A likely due to structural similarity of the DNA‐binding CXXC domains. DEC influences KMT2A downstream processes and synergizes with menin inhibitor revumenib (REV) to decrease leukemic cell proliferation, and
Luisa Brock   +10 more
wiley   +1 more source

NHEP Water Quality Funding Sources [PDF]

open access: yes, 2004
The New Hampshire Estuaries Project (NHEP) Management Plan, published in 2000, sets forth three goals related to estuarine water quality in the State’s coastal watershed, and twenty Water Quality Action Plans to implement these goals.
Craig, Matt
core   +2 more sources

Home - About - Disclaimer - Privacy